Novo Nordisk (NVO) shares hit their highest level in over two months following a Financial Times report that activist hedge ...

Aleniglipron’s tolerability could be a differentiator for Structure Therapeutics, but its efficacy lags competitors. Read why ...

Stigma and misinformation are hindering many Filipinos with obesity from getting the care they need, a psychiatrist warned as ...